Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
The global peritoneal dialysis market size is expected to grow at a CAGR of 6.40% in the forecast period of 2023-2028, owing to the rising prevalence of chronic kidney disease.
With peritoneal dialysis (PD), a soft plastic tube or catheter is surgically implanted into the abdominal lining or belly to treat kidney failure. The two types of peritoneal dialysis are continuous ambulatory peritoneal dialysis (CAPD) and continuous cycling peritoneal dialysis (CCPD). These methods enable more flexible treatment options, lessen the need to visit dialysis facilities, and produce better clinical results, which means less drugs and fewer dietary restrictions.
Based on treatment type, the market is segmented into continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). The market on the basis of product can be divided into peritoneal dialysis solution, peritoneal dialysis devices, peritoneal dialysis sets, and peritoneal dialysis catheters, among others. On the basis of end use, the market is divided into home-based dialysis and dialysis centre and hospital-based dialysis. The regional markets for peritoneal dialysis can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global peritoneal dialysis market, covering their competitive landscape and latest developments like mergers, acquisitions, investments, and expansion plans.
The continuous ambulatory peritoneal dialysis (CAPD) market is anticipated to have significant revenue growth during the forecast period. CAPD is a type of peritoneal dialysis that can be done manually, without a machine, and constantly throughout the day. The method is new for the treatment of end-stage renal disease. The benefits include improved blood pressure management, a discernible improvement in anaemia, and an unrestricted diet, thus aiding the peritoneal dialysis market growth.
Additionally, CAPD provides a greater clearance of medicines with a higher molecular weight than haemodialysis. Both therapies are intended to be performed over a 24-hour period, however CAPD does not employ a cycler and APD does. The cycler is a programmable machine that controls the solution exchange, enabling usage of APDs throughout the night while the patient is asleep.
North America is anticipated to hold one of the largest market shares during the forecast period. This is due to the high awareness of the peritoneal dialysis technology, the established healthcare industry, and the rising incidence of end-stage renal disease (ESRD) and chronic kidney disease (CKD).
An increase in CKD patients in North America has been caused by the rising numbers of people with diabetes and high blood pressure. This has caused a sharp increase in the demand for peritoneal dialysis among kidney patients, which is anticipated to propel the peritoneal dialysis market in the region. Additionally, the existence of significant producers like Baxter, and other leading producers has improved access to a variety of dialysis products at competitive prices, which is anticipated to fuel the regional market growth.
Baxter International, Inc., which was established in 1931 and has its headquarters in the United States, offers a variety of medical supplies. Its product and service offerings include sterile intravenous solutions, generic injectable medications, parenteral nutrition therapy, infusion systems and devices, inhaled anaesthetics, surgical haemostat and sealant products, and dialysis for both acute and chronic illnesses.
B. Braun Melsungen AG, since its founding in 1839 has developed, produced, and distributed pharmaceutical and medical technology goods as well as offered healthcare services. B. Braun sells equipment and systems for surgery, extracorporeal blood transfusion, intensive care, and anaesthesia. Additionally, it provides services for medical practises, clinics, and the home health care industry.
Fresenius Medical Care AG & Co. KGaA, a global healthcare company with its headquarters in Germany and founded in 1996, provides high-quality goods and services for hospitals, outpatient care, and dialysis, with about 3.8 million patients receiving dialysis on a regular basis globally.
Other market players include Medtronic plc, Medionics International Inc., and Newsol Technologies Inc., among others.
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Treatment Type||
|Breakup by Product||
|Breakup by End Use||
|Breakup by Region||
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
7 Industry Opportunities and Challenges
8 Global Peritoneal Dialysis Market Analysis
8.1 Key Industry Highlights
8.2 Global Peritoneal Dialysis Historical Market (2018-2022)
8.3 Global Peritoneal Dialysis Market Forecast (2023-2028)
8.4 Global Peritoneal Dialysis Market by Treatment Type
8.4.1 Continuous Ambulatory Peritoneal Dialysis (CAPD)
18.104.22.168 Market Share
22.214.171.124 Historical Trend (2018-2022)
126.96.36.199 Forecast Trend (2023-2028)
8.4.2 Automated Peritoneal Dialysis (APD)
188.8.131.52 Market Share
184.108.40.206 Historical Trend (2018-2022)
220.127.116.11 Forecast Trend (2023-2028)
8.5 Global Peritoneal Dialysis Market by Product
8.5.1 Peritoneal Dialysis Solution
18.104.22.168 Market Share
22.214.171.124 Historical Trend (2018-2022)
126.96.36.199 Forecast Trend (2023-2028)
8.5.2 Peritoneal Dialysis Devices
188.8.131.52 Market Share
184.108.40.206 Historical Trend (2018-2022)
220.127.116.11 Forecast Trend (2023-2028)
8.5.3 Peritoneal Dialysis Sets
18.104.22.168 Market Share
22.214.171.124 Historical Trend (2018-2022)
126.96.36.199 Forecast Trend (2023-2028)
8.5.4 Peritoneal Dialysis Catheters
188.8.131.52 Market Share
184.108.40.206 Historical Trend (2018-2022)
220.127.116.11 Forecast Trend (2023-2028)
8.6 Global Peritoneal Dialysis Market by End Use
8.6.1 Home-based Dialysis
18.104.22.168 Market Share
22.214.171.124 Historical Trend (2018-2022)
126.96.36.199 Forecast Trend (2023-2028)
8.6.2 Dialysis Centre and Hospital-based Dialysis
188.8.131.52 Market Share
184.108.40.206 Historical Trend (2018-2022)
220.127.116.11 Forecast Trend (2023-2028)
8.7 Global Peritoneal Dialysis Market by Region
8.7.1 Market Share
18.104.22.168 North America
22.214.171.124 Asia Pacific
126.96.36.199 Latin America
188.8.131.52 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.1.3 Breakup by Country
184.108.40.206 United States of America
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.2.3 Breakup by Country
220.127.116.11 United Kingdom
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.3.3 Breakup by Country
9.4 Latin America
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
9.4.3 Breakup by Country
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2022)
9.5.2 Forecast Trend (2023-2028)
9.5.3 Breakup by Country
18.104.22.168 Saudi Arabia
22.214.171.124 United Arab Emirates
126.96.36.199 South Africa
10 Market Dynamics
10.1 SWOT Analysis
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Baxter International, Inc.
188.8.131.52 Company Overview
184.108.40.206 Product Portfolio
220.127.116.11 Demographic Reach and Achievements
11.2.2 B. Braun Melsungen AG
18.104.22.168 Company Overview
22.214.171.124 Product Portfolio
126.96.36.199 Demographic Reach and Achievements
11.2.3 Fresenius Medical Care AG & Co. KGaA
188.8.131.52 Company Overview
184.108.40.206 Product Portfolio
220.127.116.11 Demographic Reach and Achievements
11.2.4 Medtronic plc
18.104.22.168 Company Overview
22.214.171.124 Product Portfolio
126.96.36.199 Demographic Reach and Achievements
11.2.5 Medionics International Inc.
188.8.131.52 Company Overview
184.108.40.206 Product Portfolio
220.127.116.11 Demographic Reach and Achievements
11.2.6 Newsol Technologies Inc.
18.104.22.168 Company Overview
22.214.171.124 Product Portfolio
126.96.36.199 Demographic Reach and Achievements
12 Industry Events and Developments
List of Key Figures and Tables
1. Global Peritoneal Dialysis Market: Key Industry Highlights, 2017 and 2027
2. Global Peritoneal Dialysis Historical Market: Breakup by Treatment Type (USD Million), 2018-2022
3. Global Peritoneal Dialysis Market Forecast: Breakup by Treatment Type (USD Million), 2023-2028
4. Global Peritoneal Dialysis Historical Market: Breakup by Product (USD Million), 2018-2022
5. Global Peritoneal Dialysis Market Forecast: Breakup by Product (USD Million), 2023-2028
6. Global Peritoneal Dialysis Historical Market: Breakup by End Use (USD Million), 2018-2022
7. Global Peritoneal Dialysis Market Forecast: Breakup by End Use (USD Million), 2023-2028
8. Global Peritoneal Dialysis Historical Market: Breakup by Region (USD Million), 2018-2022
9. Global Peritoneal Dialysis Market Forecast: Breakup by Region (USD Million), 2023-2028
10. North America Peritoneal Dialysis Historical Market: Breakup by Country (USD Million), 2018-2022
11. North America Peritoneal Dialysis Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Europe Peritoneal Dialysis Historical Market: Breakup by Country (USD Million), 2018-2022
13. Europe Peritoneal Dialysis Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Asia Pacific Peritoneal Dialysis Historical Market: Breakup by Country (USD Million), 2018-2022
15. Asia Pacific Peritoneal Dialysis Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Latin America Peritoneal Dialysis Historical Market: Breakup by Country (USD Million), 2018-2022
17. Latin America Peritoneal Dialysis Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Middle East and Africa Peritoneal Dialysis Historical Market: Breakup by Country (USD Million), 2018-2022
19. Middle East and Africa Peritoneal Dialysis Market Forecast: Breakup by Country (USD Million), 2023-2028
20. Global Peritoneal Dialysis Market Structure
The market is projected to grow at a CAGR of 6.40% between 2023 and 2028.
The major drivers of the peritoneal dialysis market include the increasing cases of hypertension, diabetes, and end-stage renal disease (ESRD), the growing prevalence of chronic kidney disease (CKD), and the shifting inclination of health practitioners toward PD over haemodialysis.
The extensive investments in research and development activities by governments, improving reimbursement policies, ongoing product diversification, and well-established healthcare sector are the key industry trends propelling the growth of the market.
The major players in the industry are Baxter International, Inc., B. Braun Melsungen AG, Fresenius Medical Care AG & Co. KGaA, Medtronic plc, Medionics International Inc., and Newsol Technologies Inc., among others.
The most typical kind of PD is continuous ambulatory peritoneal dialysis. Self-dialysis of this kind is performed every day of the week, with four to five exchanges of fresh solutions per day.
While the functionality of peritoneal dialysis and haemodialysis are similar, peritoneal dialysis is safer as it can be conducted regularly, preventing build-up of fluids. As haemodialysis requires visits to a centre dialysis, risks of missing appointments and build-ups of fluid is higher.
Infection is one of the most dangerous complications of peritoneal dialysis and can appear in the skin around the catheter or inside the abdominal cavity in the form of peritonitis. The development of a hernia, a weakening in the abdominal muscles, is another potential but less severe side effect of peritoneal dialysis.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.